Drawing for LUER-JACK

USPTO serial 85632345

LUER-JACK

Reviewed by CopyMark Law Group

Reg. 4554112Status 710
Filing date
Status date
Registration date
Jun 24, 2014
Examiner
ANKRAH, NAAKWAMA S
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with LUER-JACK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Stabe

Susan Stabe Troutman Pepper Hamilton Sanders LLP600 Peachtree Street, NE, Suite 3000Atlanta, GA 30308UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pre-filled syringes, vials, bags and other drug or fluid delivery, transfer and extraction devices containing saline solutions, sterile water, prenatal nutrients, nutritional solutions, solutions comprising water and pharmaceuticals to prevent blood clotting in pipes, syringes and couplings; pre-filled syringes, vials, bags and other drug or fluid delivery, transfer and extraction devices containing pharmaceutical and veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, apparatus and instruments for surgical, medical, dental or veterinary purposes containing pharmaceuticals; syringes, vials, bags and other drug or fluid delivery, transfer and extraction devices, apparatus and instruments pre-filled with saline solutions or other fluids for surgical, medical, dental or veterinary purposesSECTION 8 - CANCELLED—
010Drug and fluid delivery, transfer and extraction devices, apparatus and instruments for medical use; injectors for medical purposes; fluid extractors for medical purposes; medical apparatus for intravenous administration of fluids or pharmaceuticals; medical apparatus for intravenous extraction of blood; catheters; infusion and injection devices for pharmaceuticals; injection apparatus and instruments with and without needles for administering drugs and fluids for medical purposes; disposable, hypodermic and injection syringes and needles for administering drugs and fluids for medical purposes; injection syringes, syringe barrels; medical needles and introducers; pipes and tubes for surgical, medical, dental and veterinary purposes; bags for holding fluids, extractions or pharmaceuticals for surgical, medical, dental and veterinary purposes; ejector tools and devices for use with syringes, catheters, pipes, tubes, bags and other infusion, injection and drug or fluid delivery, transfer and extraction devices, apparatus and instruments for medical purposes; ejector tools and devices, including levers and sliders, for use with or integrated into syringes, catheters, pipes, tubes, bags and other infusion, injection and drug or fluid delivery, transfer and extraction devices, apparatus and instruments to enable easy release of connecting parts all for medical purposes; nozzles, attachments, collars, connectors and fittings for syringes, catheters, pipes, tubes, bags and other infusion, injection and drug or fluid delivery, transfer and extraction devices, apparatus and instruments for medical use; attachments, collars, connectors and fittings for needles that permit easy connection and removal from syringes, catheters, pipes, tubes, bags and other infusion, injection and drug or fluid delivery, transfer and extraction devices, apparatus and instruments for medical use; Luer taper or Luer slip connectors for medical use; medical devices and surgical instruments, namely, medical Luer taper or Luer slip caps, adaptors, connectors and fitting; parts and fittings for the aforesaidSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2021C8..CANCELLED SEC. 8 (6-YR)—
Nov 20, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 20, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 20, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 20, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 20, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 24, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 7, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 7, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 24, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 2014DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Mar 28, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 3, 2014IUCNNOTICE OF ALLOWANCE CANCELLED—
Mar 3, 2014EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Sep 10, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 10, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2013ALIEASSIGNED TO LIE—
May 23, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 23, 2013XAECEXAMINER'S AMENDMENT ENTERED—
May 23, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 23, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
May 23, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 1, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 10, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2013ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 19, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 12, 2012GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 12, 2012GNSLLETTER OF SUSPENSION E-MAILED—
Sep 12, 2012CNSLSUSPENSION LETTER WRITTEN—
Sep 11, 2012DOCKASSIGNED TO EXAMINER—
May 30, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 25, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance